Accessibility Menu
 
Cannabis Strategic Ventures logo

Cannabis Strategic Ventures

(OTC) NUGS

Current Price$0.00
Market Cap$486,000
Since IPO (2005)-81%
5 Year-99%
1 Year+119,900%
1 Month+20%

Cannabis Strategic Ventures Financials at a Glance

Market Cap

$486,000

Revenue (TTM)

$4.79M

Net Income (TTM)

$9.87M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

73.09 (High)

Price

$0.00

Volume

120

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

NUGS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannabis Strategic Ventures

Industry

Pharmaceuticals

CEO

Simon Yu, MBA

Headquarters

Los Angeles, CA 90014, US

NUGS Financials

Key Financial Metrics (TTM)

Gross Margin

9%

Operating Margin

-73%

Net Income Margin

-87%

Return on Equity

0%

Return on Capital

1%

Return on Assets

-77%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$486.00K

Shares Outstanding

405.00M

Volume

120

Avg. Volume

31.94K

Financials (TTM)

Gross Profit

$921.73K

Operating Income

$7.22M

EBITDA

$5.70M

Operating Cash Flow

$1.43M

Capital Expenditure

$4.00

Free Cash Flow

$1.43M

Cash & ST Invst.

$25.19K

Total Debt

$13.85M

Cannabis Strategic Ventures Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2022YOY CHG

Revenue

$57.88K

-98.9%

Gross Profit

$54.61K

-103.6%

Gross Margin

-94.36%

N/A

Market Cap

$486.00K

N/A

Market Cap/Employee

$16.20K

N/A

Employees

30

N/A

Net Income

$1.80M

-239.9%

EBITDA

$1.66M

-1082.4%

Quarterly Fundamentals

Name
Q2 2022YOY CHG

Net Cash

$13.55M

+36.6%

Accounts Receivable

$24.11K

-95.9%

Inventory

$2.32M

+4.2%

Long Term Debt

$1.76M

-63.0%

Short Term Debt

$11.81M

-30.2%

Return on Assets

-76.96%

N/A

Return on Invested Capital

1.18%

N/A

Free Cash Flow

$2.33M

-367.7%

Operating Cash Flow

$2.33M

-367.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PTLFPetlife Pharmaceuticals, Inc.
$0.00+0.00%
HSMDHealthcare Solutions Management Group, Inc.
$0.00+0.00%
AOLSAeolus Pharmaceuticals, Inc.
$0.00+0.00%
HCANFHalo Collective Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%
SOUNSoundHound AI
$9.56+0.20%

Questions About NUGS

What is the current price of Cannabis Strategic Ventures?

Cannabis Strategic Ventures is trading at $0.00 per share.

What is the 52-week range for Cannabis Strategic Ventures?

Over the past 52 weeks, Cannabis Strategic Ventures has traded between $0.00 and $0.01.

How much debt does Cannabis Strategic Ventures have?

As of the most recent reporting period, Cannabis Strategic Ventures reported total debt of $13.85M.

How much cash does Cannabis Strategic Ventures have on hand?

Cannabis Strategic Ventures reported $25,192 in cash and cash equivalents in its most recent financial results.

What is Cannabis Strategic Ventures’s dividend yield?

Cannabis Strategic Ventures does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.